Viridian Therapeutics, Inc. VRDN Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share)?
- Viridian Therapeutics, Inc. (VRDN) reported common stock, par value (in dollars per share) of $0.01 in Q1 2026.
- How has Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.